2011
DOI: 10.1002/cbic.201100437
|View full text |Cite
|
Sign up to set email alerts
|

Photoactivatable Caged Cyclic RGD Peptide for Triggering Integrin Binding and Cell Adhesion to Surfaces

Abstract: We report on the synthesis and properties of a photoactivatable caged RGD peptide and its application for phototriggering integrin and cell binding to surfaces. We analyzed in detail (i) the differences in the integrin binding affinity of the caged and uncaged forms via quartz crystal microbalance (QCM) studies, (ii) the efficiency and yield of the photolytic uncaging reaction, (iii) the biocompatibility of the photolysis byproducts and irradiation conditions and (iv) the possibility of site, temporal and dens… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
65
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 71 publications
(66 citation statements)
references
References 38 publications
1
65
0
Order By: Relevance
“…1 H NMR (300 MHz, CDCl 3 ) ı 7.37 (d, 1H, J = 9 Hz), 6.51 (dd, 1H, J = 9.3 Hz, 2.4 Hz), 6.39 (d, 1H, J = 2.7 Hz), 6.23 (s, 1H), 5.09 (q, 1H, J = 6.6 Hz), 3.34 (q, 4H, J = 6.9 Hz), 1.49 (d, 3H, J = 6.6 Hz), 1.41 (t, 3H, J = 6.9 Hz). 13 …”
Section: -(Nn-diethylamino)-4-(hydroxymethyl)-coumarin (2)mentioning
confidence: 97%
See 2 more Smart Citations
“…1 H NMR (300 MHz, CDCl 3 ) ı 7.37 (d, 1H, J = 9 Hz), 6.51 (dd, 1H, J = 9.3 Hz, 2.4 Hz), 6.39 (d, 1H, J = 2.7 Hz), 6.23 (s, 1H), 5.09 (q, 1H, J = 6.6 Hz), 3.34 (q, 4H, J = 6.9 Hz), 1.49 (d, 3H, J = 6.6 Hz), 1.41 (t, 3H, J = 6.9 Hz). 13 …”
Section: -(Nn-diethylamino)-4-(hydroxymethyl)-coumarin (2)mentioning
confidence: 97%
“…13 C NMR spectra were recorded on a Bruker Spectrospin 75 Hz. ESI-MS spectra were recorded using a QTos Ultima 3 (Micromass/Waters, Manchester, UK).…”
Section: General Informationmentioning
confidence: 99%
See 1 more Smart Citation
“…Future cell-based strategies must consider the temporal and spatial complexities of the in vivo environment and the effect or role of cellular retention and engraftment for regenerative medicine. In addition to strategies previously mentioned, future considerations for engineering a cell delivery vehicle include dynamic or triggered changes in bioactivity [54,55], as well as multiple growth factor delivery for synergistic effects in directing cell fate [56]. Understanding, harnessing, and engineering these aspects into a cell-delivery vehicle may finally enable us to use cells to their full potential as a tissue repair therapy strategy.…”
Section: Looking Forwardmentioning
confidence: 99%
“…Published works report the coating or tailoring of biomaterials with bioactive molecules, such as fibronectin [3], laminin [4], growth factors [5,6] or their integrin-binding epitopes including RGD [7,8] and GFOGER [9]. These studies report the influence of such biomolecules in cell adhesion, differentiation or proliferation.…”
Section: Introductionmentioning
confidence: 99%